Research from Geisinger Medical Center shows Roux-en-Y gastric bypass surgery holds type 2 diabetes in remission for 15 years and supports sustainable weight loss for 20 years, underscoring its long-term effectiveness over other treatments. Gastric bypass keeps diabetes in remission for 15 years and weight loss maintained for 20 years, according to a large, long-term study. Roux-en-Y gastric bypass, a type of weight-loss surgery, kept type 2 diabetes in remission for up to 15 years and most of the weight off for up to 20 years in one of the largest long-term studies of patients undergoing the procedure.
The study “Long Term (> 15 Year) Outcomes Following Roux-en-Y Gastric Bypass” will be presented today (June 12) at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2024 Annual Scientific Meeting. Study Details and Initial Findings Researchers from Geisinger Medical Center in Danville, Pennsylvania analyzed diabetes remission rates and weight-loss outcomes of 2,045 patients who had a gastric bypass at their center between 2001 and 2008 and followed them for up to 20 years. Patients, on average, were 46 years old with a body mass index (BMI) of 47.
9, prior to surgery. Of the 677 patients with pre-operative diabetes, remission rates were 54% at the three-year mark but dropped to 38% after 15 years. Only about 10% of patients with insulin -dependent diabetes had remission in the same timeframe and the rate of persistent diabetes was higher in patients who had i.
